Facephi Biometria, S.A. (FACE.MC) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+10.0%

€1.80

vs €1.64 price

Levered DCF

€7.10

After debt service

Piotroski score

8 / 9

Strong

Altman Z-score

1.73

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	182.01×	-4.51×	-10×	39×	-106.5×	-39.08×	32.57×	8.42×
P/B	3.07×	2.11×	2.11×	2.84×	6.78×	10.4×	9.57×	3.8×
P/S	1.86×	1.4×	1.44×	1.94×	4.49×	10.05×	5.12×	2.19×
EV / EBITDA	9.16×	-205.37×	-81×	14.89×	77.85×	-71.75×	19.4×	9.36×
Gross margin	63.2%	45.7%	88.3%	102.8%	102.3%	96.0%	93.9%	108.1%
Operating margin	10.1%	-23.1%	-18.4%	7.8%	-4.6%	-5.0%	23.6%	20.4%
Net margin	1.0%	-30.8%	-14.7%	5.0%	-4.2%	-25.5%	15.7%	26.1%
Current ratio	1.12×	1.08×	0.85×	1.24×	2.33×	3.95×	1.41×	1.32×
Debt / equity	0.33×	0.53×	0.65×	0.51×	0.71×	1×	0.7×	0.96×
Interest coverage	4.31×	-4.38×	-3.15×	5.82×	-1.54×	-2.8×	15.62×	16.48×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	1.7%	-46.3%	-21.5%	7.3%	-6.4%	-26.4%	29.4%	45.1%
Return on invested capital	12.1%	-20.9%	-9.9%	7.4%	-2.6%	-2.4%	19.3%	17.6%
Return on assets	0.8%	-17.9%	-9.4%	3.4%	-3.0%	-11.6%	11.6%	17.7%
Free cash flow yield	-2.1%	-11.2%	-1.6%	-18.3%	-10.4%	-1.2%	-2.4%	-2.6%
Earnings yield	0.6%	-21.9%	-10.2%	2.6%	-0.9%	-2.5%	3.1%	11.9%
Enterprise value	€72.3M	€45.2M	€52.5M	€49.1M	€63.9M	€74M	€44.6M	€11.9M
Net debt / EBITDA	0.67×	-21.16×	-15.78×	1.8×	5.94×	-1.03×	1.17×	1.65×
Cash conversion cycle (days)	48	117	-234	514	752	-88	364	308